109 related articles for article (PubMed ID: 38761579)
1. Design and anticancer behaviour of cationic/neutral half-sandwich iridium(III) imidazole-phenanthroline/phenanthrene complexes.
Lv A; Li G; Zhang P; Tao R; Li X; Ren X; Li P; Liu X; Yuan XA; Liu Z
J Inorg Biochem; 2024 Aug; 257():112612. PubMed ID: 38761579
[TBL] [Abstract][Full Text] [Related]
2. Novel and Versatile Imine-N-Heterocyclic Carbene Half-Sandwich Iridium(III) Complexes as Lysosome-Targeted Anticancer Agents.
Yang Y; Guo L; Tian Z; Gong Y; Zheng H; Zhang S; Xu Z; Ge X; Liu Z
Inorg Chem; 2018 Sep; 57(17):11087-11098. PubMed ID: 30133276
[TBL] [Abstract][Full Text] [Related]
3. Highly potent half-sandwich iridium and ruthenium complexes as lysosome-targeted imaging and anticancer agents.
Li J; Tian Z; Xu Z; Zhang S; Feng Y; Zhang L; Liu Z
Dalton Trans; 2018 Nov; 47(44):15772-15782. PubMed ID: 30357192
[TBL] [Abstract][Full Text] [Related]
4. Ferrocene-modified half-sandwich iridium(III) and ruthenium(II) propionylhydrazone complexes and anticancer application.
Ji C; Dong R; Zhang P; Tao R; Wang X; Dai Q; Liu X; Yuan XA; Zhang S; Yue M; Liu Z
J Inorg Biochem; 2024 Aug; 257():112586. PubMed ID: 38728860
[TBL] [Abstract][Full Text] [Related]
5. The anticancer application of half-sandwich iridium(III) ferrocene-thiosemicarbazide Schiff base complexes.
Liu X; Lv A; Zhang P; Chang J; Dong R; Liu M; Liu J; Huang X; Yuan XA; Liu Z
Dalton Trans; 2024 Jan; 53(2):552-563. PubMed ID: 38054240
[TBL] [Abstract][Full Text] [Related]
6. Configurationally regulated half-sandwich iridium(III)-ferrocene heteronuclear metal complexes: Potential anticancer agents.
Liu X; Wang Z; Zhang X; Lv X; Sun Y; Dong R; Li G; Ren X; Ji Z; Yuan XA; Liu Z
J Inorg Biochem; 2023 Dec; 249():112393. PubMed ID: 37806004
[TBL] [Abstract][Full Text] [Related]
7. Lysosome-targeted chemotherapeutics: Anticancer mechanism of N-heterocyclic carbene iridium(III) complex.
Zhang J; Liu J; Liu X; Liu B; Song S; He X; Che C; Si M; Yang G; Liu Z
J Inorg Biochem; 2020 Jun; 207():111063. PubMed ID: 32222581
[TBL] [Abstract][Full Text] [Related]
8. Anticancer application of ferrocene appended configuration-regulated half-sandwich iridium(III) pyridine complexes.
Wang Z; Lv Z; Liu X; Wu Y; Chang J; Dong R; Li C; Yuan XA; Liu Z
J Inorg Biochem; 2022 Dec; 237():112010. PubMed ID: 36152469
[TBL] [Abstract][Full Text] [Related]
9. Induction of apoptosis in SGC-7901 cells by iridium(III) complexes via endoplasmic reticulum stress-mitochondrial dysfunction pathway.
Wang J; Liu H; Wu X; Shi C; Li W; Yuan Y; Liu Y; Xing D
J Biol Inorg Chem; 2022 Aug; 27(4-5):455-469. PubMed ID: 35817878
[TBL] [Abstract][Full Text] [Related]
10. In Vitro and In Vivo of Triphenylamine-Appended Fluorescent Half-Sandwich Iridium(III) Thiosemicarbazones Antitumor Complexes.
Shao M; Yao M; Liu X; Gao C; Liu W; Guo J; Zong J; Sun X; Liu Z
Inorg Chem; 2021 Nov; 60(22):17063-17073. PubMed ID: 34709784
[TBL] [Abstract][Full Text] [Related]
11. Anticancer and antibacterial activity in vitro evaluation of iridium(III) polypyridyl complexes.
Yi QY; Zhang WY; He M; Du F; Wang XZ; Wang YJ; Gu YY; Bai L; Liu YJ
J Biol Inorg Chem; 2019 Mar; 24(2):151-169. PubMed ID: 30564887
[TBL] [Abstract][Full Text] [Related]
12. Significant effects of counteranions on the anticancer activity of iridium(iii) complexes.
Zhang H; Guo L; Tian Z; Tian M; Zhang S; Xu Z; Gong P; Zheng X; Zhao J; Liu Z
Chem Commun (Camb); 2018 Apr; 54(35):4421-4424. PubMed ID: 29648559
[TBL] [Abstract][Full Text] [Related]
13. Anticancer effect evaluation in vitro and in vivo of iridium(III) polypyridyl complexes targeting DNA and mitochondria.
Zhang H; Tian L; Xiao R; Zhou Y; Zhang Y; Hao J; Liu Y; Wang J
Bioorg Chem; 2021 Oct; 115():105290. PubMed ID: 34426145
[TBL] [Abstract][Full Text] [Related]
14. New Organometallic Tetraphenylethylene⋅Iridium(III) Complexes with Antineoplastic Activity.
Liu X; He X; Zhang X; Wang Y; Liu J; Hao X; Zhang Y; Yuan XA; Tian L; Liu Z
Chembiochem; 2019 Nov; 20(21):2767-2776. PubMed ID: 31119850
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial targeting half-sandwich iridium(III) and ruthenium(II) dppf complexes and in vitro anticancer assay.
Liu J; Wu Y; Yang G; Liu Z; Liu X
J Inorg Biochem; 2023 Feb; 239():112069. PubMed ID: 36423395
[TBL] [Abstract][Full Text] [Related]
16. Preparation and Bioactivity of Iridium(III) Phenanthroline Complexes with Halide Ions and Pyridine Leaving Groups.
Liu X; Shao M; Liang C; Guo J; Wang G; Yuan XA; Jing Z; Tian L; Liu Z
Chembiochem; 2021 Feb; 22(3):557-564. PubMed ID: 32964620
[TBL] [Abstract][Full Text] [Related]
17. The Fluorine Effect in Zwitterionic Half-Sandwich Iridium(III) Anticancer Complexes.
Yang Y; Guo L; Ge X; Zhu T; Chen W; Zhou H; Zhao L; Liu Z
Inorg Chem; 2020 Jan; 59(1):748-758. PubMed ID: 31808678
[TBL] [Abstract][Full Text] [Related]
18. Mitochondria-targeted phosphorescent cyclometalated iridium(III) complexes: synthesis, characterization, and anticancer properties.
Li Y; Liu B; Xu CX; He L; Wan YC; Ji LN; Mao ZW
J Biol Inorg Chem; 2020 Jun; 25(4):597-607. PubMed ID: 32232583
[TBL] [Abstract][Full Text] [Related]
19. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z
Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963
[TBL] [Abstract][Full Text] [Related]
20. In Vitro and In Vivo Antitumor Assay of Mitochondrially Targeted Fluorescent Half-Sandwich Iridium(III) Pyridine Complexes.
Wang L; Liu X; Wu Y; He X; Guo X; Gao W; Tan L; Yuan XA; Liu J; Liu Z
Inorg Chem; 2023 Feb; 62(8):3395-3408. PubMed ID: 36763897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
